CLOs on the Move

Vernalis

www.vernalis.com

 
Vernalis plc is a revenue generating development stage pharmaceutical company with one marketed product, frovatriptan, and a broad pipeline of research and development programmes. The business model is a balance between risk and innovation with the aim of creating value through a focused and disciplined strategy. An exclusive development and licensing agreement with Tris Pharma to develop multiple novel products focussed on the US prescription cough cold market is the platform for Vernalis to build a profitable and cash generative commercial business in the US. These novel products are low risk, late stage and differentiated for an unmet need. Value ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.vernalis.com
  • 1000 Westlakes Drive Suite 200
    Berwyn, PA USA 19312
  • Phone: 484.913.0700

Executives

Name Title Contact Details

Similar Companies

Foresight

Find the most effective and affordable therapy, counseling, and treatments with Foresight! With our advanced technology, we make sure to provide the most effective and accurate treatment to our patients. We accept most insurances, so book today and sta...

Center for Autism and Related Disorders

The Center for Autism and Related Disorders, Inc.

Francks Pharmacies

Francks Pharmacies is a Ocala, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sun Pharma

Sun Pharma is the world`s fourth largest specialty generic pharmaceutical company and India`s top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world. Sun Pharma`s global presence is supported by 50 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of over 7% of annual revenues.